Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-10-20 00:00:00 ET · period of report 2025-10-17 · accession 0001106578-25-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-10-20 | 2025-10-17+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-20 | 2025-10-17+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $427.63 | -8,000 | 2,531 | -76% | -$3.42M |
| DMT | 2025-10-20 | 2025-10-17+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $0.00 | -8,000 | 170.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-17 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-17 | S | D | 2,900 | $430.05 | 1,230 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $429.65 to $430.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-10-17 | S | D | 1,100 | $432.31 | 130 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $432.23 to $432.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-10-20 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 5 | Common | Common Stock | 2025-10-20 | S | D | 500 | $434.22 | 130 | D | — | — | |
| 6 | Common | Common Stock | 2025-10-20 | S | D | 200 | $422.30 | 2,331 | D | — | — | |
| 7 | Common | Common Stock | 2025-10-20 | S | D | 1,301 | $424.68 | 1,030 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $424.575 to $425.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2025-10-20 | S | D | 400 | $427.56 | 630 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $427.55 to $427.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2025-10-20 | S | D | 1,599 | $421.04 | 2,531 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $420.62 to $421.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Derivative | Stock Option | 2025-10-17 | M | D | 4,000 | $0.00 | 174,000 | D | $120.26 · 2016-03-15 to 2026-03-15 | 4,000 Common Stock | |
| 11 | Derivative | Stock Option | 2025-10-20 | M | D | 4,000 | $0.00 | 170,000 | D | $120.26 · 2016-03-15 to 2026-03-15 | 4,000 Common Stock |